851 related articles for article (PubMed ID: 33516602)
21. Probability of Success and Timelines for the Development of Vaccines for Emerging and Reemerged Viral Infectious Diseases.
MacPherson A; Hutchinson N; Schneider O; Oliviero E; Feldhake E; Ouimet C; Sheng J; Awan F; Wang C; Papenburg J; Basta NE; Kimmelman J
Ann Intern Med; 2021 Mar; 174(3):326-334. PubMed ID: 33226855
[TBL] [Abstract][Full Text] [Related]
22. Emergency Use Authorizations (EUAs) Versus FDA Approval: Implications for COVID-19 and Public Health.
Zuckerman DM
Am J Public Health; 2021 Jun; 111(6):1065-1069. PubMed ID: 33950730
[No Abstract] [Full Text] [Related]
23. Placebo-controlled trials with COVID-19 vaccines: participants first.
Dal-Ré R
J Clin Epidemiol; 2021 Oct; 138():211-212. PubMed ID: 34271109
[No Abstract] [Full Text] [Related]
24. The Advisory Committee on Immunization Practices' Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines - United States, 2021.
Mbaeyi S; Oliver SE; Collins JP; Godfrey M; Goswami ND; Hadler SC; Jones J; Moline H; Moulia D; Reddy S; Schmit K; Wallace M; Chamberland M; Campos-Outcalt D; Morgan RL; Bell BP; Brooks O; Kotton C; Talbot HK; Lee G; Daley MF; Dooling K
MMWR Morb Mortal Wkly Rep; 2021 Nov; 70(44):1545-1552. PubMed ID: 34735422
[TBL] [Abstract][Full Text] [Related]
25. Casirivimab and imdevimab (REGEN-COV) for post-exposure prophylaxis of COVID-19.
Med Lett Drugs Ther; 2021 Aug; 63(1631):130-131. PubMed ID: 34544100
[No Abstract] [Full Text] [Related]
26. The US Regulatory System and COVID-19 Vaccines: The Importance of a Strong and Capable FDA.
Sharfstein JM; Goodman JL; Borio L
JAMA; 2021 Mar; 325(12):1153-1154. PubMed ID: 33587124
[No Abstract] [Full Text] [Related]
27. COVID-19 vaccines: concerns beyond protective efficacy and safety.
Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
[TBL] [Abstract][Full Text] [Related]
28. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021.
Woodworth KR; Moulia D; Collins JP; Hadler SC; Jones JM; Reddy SC; Chamberland M; Campos-Outcalt D; Morgan RL; Brooks O; Talbot HK; Lee GM; Bell BP; Daley MF; Mbaeyi S; Dooling K; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Nov; 70(45):1579-1583. PubMed ID: 34758012
[TBL] [Abstract][Full Text] [Related]
29. FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system.
Pawlowski C; Lenehan P; Puranik A; Agarwal V; Venkatakrishnan AJ; Niesen MJM; O'Horo JC; Virk A; Swift MD; Badley AD; Halamka J; Soundararajan V
Med; 2021 Aug; 2(8):979-992.e8. PubMed ID: 34223401
[TBL] [Abstract][Full Text] [Related]
30. Audio Interview: Covid-19 Vaccine Fundamentals.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 Dec; 383(25):e146. PubMed ID: 33326722
[No Abstract] [Full Text] [Related]
31. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
32. 2021 FDA approvals: value driven by COVID-19 vaccines.
Baedeker M; Ringel MS; Schulze U
Nat Rev Drug Discov; 2022 Feb; 21(2):90. PubMed ID: 35039671
[No Abstract] [Full Text] [Related]
33. Communicating Effectively About Emergency Use Authorization and Vaccines in the COVID-19 Pandemic.
Quinn SC; Jamison AM; Freimuth V
Am J Public Health; 2021 Mar; 111(3):355-358. PubMed ID: 33237801
[No Abstract] [Full Text] [Related]
34. Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021.
MacNeil JR; Su JR; Broder KR; Guh AY; Gargano JW; Wallace M; Hadler SC; Scobie HM; Blain AE; Moulia D; Daley MF; McNally VV; Romero JR; Talbot HK; Lee GM; Bell BP; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Apr; 70(17):651-656. PubMed ID: 33914723
[TBL] [Abstract][Full Text] [Related]
35. "When Will
Bloom BR; Nowak GJ; Orenstein W
N Engl J Med; 2020 Dec; 383(23):2202-2204. PubMed ID: 32897660
[No Abstract] [Full Text] [Related]
36. In brief: Pfizer/BioNTech COVID-19 vaccine authorized for adolescents 12-15 years old.
Med Lett Drugs Ther; 2021 May; 63(1625):81. PubMed ID: 34101717
[No Abstract] [Full Text] [Related]
37. COVID-19 vaccine trials: The potential for "hybrid" analyses.
Fleming TR; Nason M; Krause PR; Longini IM; Henao-Restrepo AM
Clin Trials; 2021 Aug; 18(4):391-397. PubMed ID: 34041932
[TBL] [Abstract][Full Text] [Related]
38. Emergency Use Authorization of COVID-19 Vaccine: Implications for Worker Communities.
Culp K; Dukes KC; Cowin C; Sinnwell E
Workplace Health Saf; 2021 Apr; 69(4):152-153. PubMed ID: 33787400
[No Abstract] [Full Text] [Related]
39. Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2021.
Dooling K; Gargano JW; Moulia D; Wallace M; Rosenblum HG; Blain AE; Hadler SC; Plumb ID; Moline H; Gerstein J; Collins JP; Godfrey M; Campos-Outcalt D; Morgan RL; Brooks O; Talbot HK; Lee GM; Daley MF; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(38):1344-1348. PubMed ID: 34555007
[TBL] [Abstract][Full Text] [Related]
40. Answering Key Questions About COVID-19 Vaccines.
Goodman JL; Grabenstein JD; Braun MM
JAMA; 2020 Nov; 324(20):2027-2028. PubMed ID: 33064145
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
